This episode is a must-listen for founders navigating the commercialization battlefield, investors allocating capital into women’s health, and operators building through the long middle before momentum is visible.
In this episode of Blindspot Capital, Maryann sits down with Cristina Ljungberg and Wendy Anderson, co-founders of The Case for Her, to unpack what happens before venture capital shows up.
For 15 years, The Case for Her has deployed catalytic capital across menstruation, sexual wellness, and reproductive health — not to replace venture capital, but to make markets legible enough for venture to follow.
What started with two women putting $5,000 each on a credit card to distribute menstrual cups evolved into one of the most catalytic platforms in global women’s health — spanning grants, debt, equity, SAFE notes, research funding, product standards, and systems-level advocacy.
This conversation is not about philanthropy versus venture. It’s about how markets form. It’s about what it takes to fund the stigmatized. And it’s about why women’s health wasn’t “uninvestable” — it was structurally invisible.
This episode is a must-listen for investors looking upstream, founders building in taboo categories, and anyone trying to understand how capital shapes what becomes visible.